1,419
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014–2018

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 367-377 | Received 04 Nov 2021, Accepted 17 Dec 2021, Published online: 04 Jan 2022

References

  • Influenza (seasonal). Geneva, Switzerland: World Health Assosiation; 2018. [updated 2018.11.06. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
  • Gran JM, Iversen B, Hungnes O, et al. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975–2004. Epidemiol Infect. 2010;138(11):1559–1568.
  • Czaja CA, Miller L, Alden N, et al. Age-related differences in hospitalization rates, clinical presentation, and outcomes among older adults hospitalized with influenza—U.S. Influenza hospitalization surveillance network (FluSurv-NET). Open Forum Infect Dis. 2019;6(7):ofz225.
  • Hauge SH, Bakken IJ, de Blasio BF, et al. Burden of medically attended influenza in Norway 2008–2017. Influenza Other Respir Viruses. 2019;13(3):240–247.
  • Oliva J, Delgado-Sanz C, Larrauri A, et al. Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010–2016. Influenza Other Respi Viruses. 2018;12(1):161–170.
  • Su S, Chaves SS, Perez A, et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza a and B virus infection. Clin Infect Dis. 2014;59(2):252–255.
  • Wang Y, Fan G, Horby P, et al. Comparative outcomes of adults hospitalized with seasonal influenza a or B virus infection: application of the 7-Category ordinal scale. Open Forum Infect Dis. 2019;6(3):ofz053.
  • Cohen R, Babushkin F, Geller K, et al. Characteristics of hospitalized adult patients with laboratory documented influenza A, B and respiratory syncytial Virus - A single center retrospective observational study. PLoS One. 2019;14(3):e0214517.
  • Delgado-Sanz C, Mazagatos-Ateca C, Oliva J, et al. Illness severity in hospitalized influenza patients by virus type and subtype, Spain, 2010–2017. Emerg Infect Dis. 2020;26(2):220–228.
  • Martinez A, Soldevila N, Romero-Tamarit A, et al. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype. PLoS One. 2019;14(1):e0210353.
  • Wie SH, So BH, Song JY, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza a or B during the 2011–2012 influenza season in Korea: a multi-center study. PLoS One. 2013;8(5):e62685.
  • Bauer TT, Ewig S, Marre R, et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med. 2006;260(1):93–101.
  • Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762–774.
  • Mulrennan S, Tempone SS, Ling IT, et al. Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One. 2010;5(9):e12849.
  • Akers IE, Weber R, Sax H, et al. Influence of time to diagnosis of severe influenza on antibiotic use, length of stay, isolation precautions, and mortality: a retrospective study. Influenza Other Respir Viruses. 2017;11(4):337–344.
  • Riquelme R, Jimenez P, Videla AJ, et al. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. The international journal of tuberculosis and lung disease: the official journal of the international union against. Int J Tuberc Lung Dis. 2011;15(4):542–546.
  • Blyth CC, Webb SA, Kok J, et al. The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respir Viruses. 2013;7(2):168–176.
  • Clark TW, Medina MJ, Batham S, et al. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect. 2014;69(5):507–515.
  • Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68(6):e1–e47.
  • Wolkewitz M, Schumacher M. Neuraminidase inhibitors and hospital mortality in British patients with H1N1 influenza A: a re-analysis of observational data. PLoS One. 2016;11(9):e0160430.
  • Katzen J, Kohn R, Houk JL, et al. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-Year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69(1):52–58.
  • Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
  • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–1655.
  • Caini S, Kroneman M, Wiegers T, et al. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review. Influenza Other Respir Viruses. 2018;12(6):780–792.
  • Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186.
  • Loubet P, Samih-Lenzi N, Galtier F, et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study. J Clin Virol. 2016;79:68–73.
  • Chagvardieff A, Persico N, Marmillot C, et al. Prospective comparative study of characteristics associated with influenza a and B in adults. Med Mal Infect. 2018;48(3):180–187.
  • Sharma Y, Horwood C, Hakendorf P, et al. Clinical characteristics and outcomes of influenza a and B virus infection in adult Australian hospitalised patients. BMC Infect Dis. 2020;20(1):913.
  • Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature. 2003;422(6930):428–433.
  • Gostic KM, Bridge R, Brady S, et al. Childhood immune imprinting to influenza a shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLoS Pathog. 2019;15(12):e1008109.
  • Lessler J, Riley S, Read JM, et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in Southern China. PLoS Pathog. 2012;8(7):e1002802.
  • Nikolich-Žugich J. The aging immune system: challenges for the 21st century. Semin Immunol. 2012;24(5):301–302.
  • Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol. 2006;27(3):266–270.
  • Falsey AR, Baran A, Walsh EE. Should clinical case definitions of influenza in hospitalized older adults include fever? Influenza Other Respir Viruses. 2015;9(1):23–29.
  • Gutierrez-Pizarraya A, Perez-Romero P, Alvarez R, et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect. 2012;65(5):423–430.
  • Haran JP, Beaudoin FL, Suner S, et al. C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness. Am J Emerg Med. 2013;31(1):137–144.
  • Ingram PR, Inglis T, Moxon D, et al. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med. 2010;36(3):528–532.
  • Dominguez A, Romero-Tamarit A, Soldevila N, et al. Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons. Epidemiol Infect. 2018;146(7):799–710.
  • Bragstad C, Hungnes O, Knudsen TH, et al. Årsrapporter for influensa. Oslo, Norway: Norwegian Institute of Public Health; 2019.